๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcome

โœ Scribed by Achille Ambrosetti; Gianpaolo Nadali; Fabrizio Vinante; Stefano Carlini; Dino Veneri; Giuseppe Todeschini; Lorella Morosato; Donata de Sabata; Marco Chilosi; Enrico Maggi; Paola Parronchi; Sergio Romagnani; Gianpietro Semenzato; Giuseppe Perona; Giovanni Pizzolo


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
538 KB
Volume
72
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Soluble interleukin-2 receptor serum lev
โœ Rolf-Markus Szeimies; Franziska Rueff; Peter Kaudewitz ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 376 KB ๐Ÿ‘ 2 views

Background. In a variety of non-Hodgkin lymphomas, a correlation between soluble interleukin-2 receptor levels (sIL-2R) and clinical stage is demonstrable. In mycosis fungoides (MF), two findings raise the question as to a similar correlation: (1) a proportion of tumor cells express IL-2 receptor an

Elevated serum levels of soluble interle
โœ Wilhelm H. Schmitt; Christoph Heesen; Elena Csernok; Annegret Rautmann; Wolfgang ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 770 KB

To investigate whether soluble interleukin-2 receptor (sIL-~R), a marker of T cell activation, could be a useful marker of disease activity in Wegener's granulomatosis (WG). Methods. Soluble IL-2R levels were determined by enzyme-linked immunosorbent assay. WG disease activity in 102 patients was a